Physician
Integrated Regional Laboratories Pathology Services, LLC
Integrated Regional Laboratories Pathology Services, LLC was paid $412K by Medicaid between Jul 2022 and Nov 2024, across 89 billing codes. Its largest line is 87426, Infectious agent antigen detection, SARS-CoV-2 (COVID-19) — 28% of everything it billed.
33Billing provider infoINTEGRATED REGIONAL LABORATORIES PATHOLOGY SERVICES, LLC
FORT PIERCE, FL 34950
FORT PIERCE, FL 34950
33aNPI1437808193assigned 03/21/2022
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$412K
24GClaims228,353
24DCodes billed89
24AFirst – last monthJul 2022 – Nov 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Florida
Rank by total paid#31 of 207
Median peer was paid$39K
This provider vs. median11×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official DAVIS, MICHAEL controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 41,157 | $65K | |
| 2023 | 102,389 | $259K | |
| 2024incomplete | 84,807 | $89K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 28% | 5,649 | 5,045 | $114K |
| 82805 | 9.9% | 2,773 | 868 | $41K | |
| 87275 | 9.0% | 8,045 | 7,525 | $37K | |
| 80053 | Comprehensive metabolic panel | 4.6% | 15,900 | 10,482 | $19K |
| 87040 | 4.3% | 5,152 | 4,275 | $18K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 3.7% | 14,424 | 6,014 | $15K |
| 85027 | 3.7% | 31,613 | 14,738 | $15K | |
| 83605 | 3.0% | 7,768 | 4,363 | $12K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2.6% | 884 | 815 | $11K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.4% | 4,864 | 4,616 | $10K |
| 84703 | 2.4% | 4,521 | 3,872 | $10K | |
| 85060 | 2.0% | 508 | 457 | $8K |
77 more codes
| 84484 | 1.9% | 6,470 | $8K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.7% | 2,223 | $7K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.5% | 112 | $6K |
| 86738 | 1.5% | 1,692 | $6K | |
| 84702 | 1.4% | 1,615 | $6K | |
| 87276 | 1.2% | 8,057 | $5K | |
| 83735 | 1.0% | 7,509 | $4K | |
| 80061 | Lipid panel | <1% | 1,051 | $4K |
| 83880 | <1% | 1,634 | $3K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,095 | $3K |
| 87807 | <1% | 3,406 | $3K | |
| 80329 | <1% | 360 | $3K | |
| 81025 | <1% | 1,795 | $3K | |
| 87070 | <1% | 5,267 | $3K | |
| 87088 | <1% | 3,653 | $3K | |
| 87077 | <1% | 1,903 | $2K | |
| 83690 | <1% | 4,856 | $2K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 896 | $2K |
| 80076 | <1% | 3,686 | $2K | |
| 88307 | <1% | 31 | $2K | |
| 86850 | <1% | 3,190 | $2K | |
| 85730 | <1% | 3,853 | $2K | |
| 82550 | <1% | 2,185 | $2K | |
| 81001 | <1% | 7,087 | $1K | |
| 82247 | <1% | 1,704 | $1K | |
| 85610 | <1% | 4,929 | $1K | |
| 86140 | <1% | 3,922 | $1K | |
| 81003 | <1% | 5,056 | $1K | |
| 80074 | <1% | 82 | $1K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 15 | $994.81 |
| 86880 | <1% | 801 | $959.56 | |
| 80202 | <1% | 330 | $899.78 | |
| 86900 | <1% | 4,198 | $847.49 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,160 | $806.16 |
| 82077 | <1% | 1,926 | $728.88 | |
| 84100 | <1% | 2,334 | $646.14 | |
| 87205 | <1% | 1,434 | $539.69 | |
| 87340 | <1% | 578 | $520.95 | |
| 87186 | <1% | 478 | $490.53 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 69 | $477.56 |
| 85379 | <1% | 792 | $350.38 | |
| 85652 | <1% | 1,584 | $325.73 | |
| 82947 | <1% | 2,511 | $310.87 | |
| 82150 | <1% | 854 | $310.58 | |
| 84132 | <1% | 3,265 | $309.02 | |
| 82140 | <1% | 196 | $298.34 | |
| 82607 | <1% | 103 | $295.85 | |
| 87075 | <1% | 195 | $263.04 | |
| 86593 | <1% | 691 | $258.22 | |
| 80069 | <1% | 453 | $256.35 | |
| 83615 | <1% | 790 | $251.28 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 274 | $239.79 |
| 82248 | <1% | 858 | $233.84 | |
| 85018 | <1% | 1,279 | $206.81 | |
| 85045 | <1% | 849 | $201.11 | |
| 84295 | <1% | 2,511 | $176.75 | |
| 82570 | <1% | 469 | $175.48 | |
| 84112 | <1% | 28 | $170.03 | |
| 82728 | <1% | 99 | $165.27 | |
| 82435 | <1% | 2,442 | $159.73 | |
| 86901 | <1% | 646 | $143.78 | |
| 86317 | <1% | 96 | $137.41 | |
| 82565 | <1% | 449 | $121.14 | |
| 85384 | <1% | 98 | $114.85 | |
| 84439 | <1% | 143 | $98.56 | |
| 84550 | <1% | 396 | $96.37 | |
| 84156 | <1% | 406 | $92.32 | |
| 83550 | <1% | 90 | $72.51 | |
| 83540 | <1% | 121 | $71.63 | |
| 82746 | <1% | 70 | $71.21 | |
| 84520 | <1% | 305 | $52.60 | |
| 86803 | <1% | 29 | $43.19 | |
| 80143 | <1% | 456 | $39.61 | |
| 86038 | <1% | 13 | $19.10 | |
| 82009 | <1% | 16 | $6.18 | |
| 82270 | <1% | 21 | $5.23 | |
| 87081 | <1% | 12 | $4.45 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDAVIS, MICHAEL (CHIEF OPERATIONS OFFICER)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.